Xenetic Biosciences, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for XBIO, updated each market day.
XBIO AI Sentiment
AI predicts Xenetic Biosciences, Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Xenetic Biosciences, Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
Sector
Exchange
Market Cap
$7,216,826
Cap Tier
Employees
2
Headquarters
FRAMINGHAM, MA
Listed Since
May 16, 2012
Website
XBIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
XBIO Volatility
Xenetic Biosciences, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
